Over the years, clinical and experimental studies have shown that, as a potential oncogene, SND1 expression is positively correlated with the progression and invasiveness of many common cancers, suggesting that SND1 may be a novel candidate gene for tumor therapy and an important indicator of prognosis (11, 14). This evidence concerns the gene SND1 and cancer.